Ventral rectopexy with biological mesh: short-term functional results

Area of Science:

• Minimally invasive surgery
• Pelvic floor disorders
• Surgical outcomes

Background:

• Ventral mesh rectopexy (VMR) is a nerve-sparing procedure for symptomatic posterior pelvic compartment issues.
• Biological mesh is utilized in VMR to address morphological changes.

Purpose of the Study:

• To evaluate the short-term functional outcomes and patient satisfaction following laparoscopic (LVMR) and robotic (RVMR) ventral mesh rectopexy (VMR) using biological mesh.
• To compare the efficacy and safety of LVMR versus RVMR.

Main Methods:

• Analysis of data from 123 patients undergoing LVMR or RVMR between August 2012 and January 2017.
• Assessment of patient demographics, surgical findings, and validated scoring systems including Cleveland Clinic Constipation Score (CCCS), Obstructed Defecation Score (ODS), and Cleveland Clinic Incontinence Score (CCIS).
• Patient satisfaction was measured using a visual analog scale (0-10).

Main Results:

• Statistically significant improvements were observed in CCCS, CCIS, and ODS at 6 and 12 months (p < 0.001).
• Excellent patient satisfaction was reported at 6 and 12 months (8.2/10 and 8.3/10, respectively).
• The overall complication rate was 14% (2% major), with no mesh-related complications. Re-intervention rate was 3%. Outcomes were comparable between LVMR and RVMR.

Conclusions:

• Laparoscopic and robotic ventral mesh rectopexy with biological mesh are safe and effective treatments for posterior pelvic compartment disorders.
• Both procedures lead to significant symptom reduction and high patient satisfaction.
• LVMR and RVMR demonstrate similar short-term functional outcomes and safety profiles.